Importantly, analysis of data from 960 breast cancer patients deposited in the TCGA (http://www.cbioportal.org) indicates that elevated expression of PLK4, AURKB and AURKC correlates with reduced survival rates (Supplementary Fig. 3h). Here, PLK4 is linked to breast carcinoma.